You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 12, 2025

Profile for Argentina Patent: 107990


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 107990

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,188,637 Mar 28, 2037 Genentech Inc ESBRIET pirfenidone
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Argentina Patent AR107990

Last updated: August 4, 2025

Introduction

Patent AR107990 pertains to a pharmaceutical invention registered in Argentina, embedding specific claims that define its scope and strategic patent coverage. Understanding the scope and claims framework of AR107990, alongside its positioning within the patent landscape, is crucial for stakeholders in the pharmaceutical industry, including innovators, legal professionals, and competitors. This detailed analysis explores the patent’s scope, claims, and contextual landscape, providing insights into its strength, breadth, and potential market implications.

Overview of Patent AR107990

Patent AR107990 was filed in Argentina, with the official registration date publicly available through the National Institute of Industrial Property (INPI) records. Although precise filing and grant dates reveal the patent's age and potential patent term, this analysis assumes the patent is active based on standard patent durations.

This patent appears to target a pharmaceutical composition or process, possibly involving a novel active ingredient, formulation, or manufacturing process tailored for therapeutic use in specific medical conditions. Its detailed claims determine the enforceable scope and define the boundaries for third-party activities.

Scope of the Patent

The scope of AR107990 hinges on its claims, framing the patent’s protective perimeter over specific innovations. Broad or narrow claim drafting influences patent strength and the ability to defend or challenge the patent.

Type of Claims

  • Product claims: Likely specify a particular active compound, composition, or formulation with detailed chemical or biological features.
  • Process claims: May describe methods for preparing the pharmaceutical composition, targeting unique manufacturing steps.
  • Use claims: Potentially cover particular therapeutic uses or indications, expanding the patent’s coverage into method-of-use territories.

Claim Breadth and Defensive Position

The scope’s breadth depends on claim wording:

  • Independent claims: Usually define the core inventive aspect, such as a novel compound or method.
  • Dependent claims: Add specific features, narrowing scope for specific embodiments.

A broad independent claim enhances patent value, deterring generics or competitors from similar developments, provided it withstands validity challenges. Conversely, narrower claims may limit enforceability but improve defensibility.

Claim Interpretation in Argentina

Argentina’s patent law adheres to a scope-of-claims doctrine similar to other civil law jurisdictions, emphasizing the literal wording and permissible interpretations, including equivalents if explicitly claimed.

Detailed Claims Analysis

While specific claim language is unavailable in this context, typical pharmaceutical patent claims encompass:

  • Chemical structure claims: Defining the molecular architecture, potentially with Markush groups or formulas.
  • Formulation claims: Covering dosage forms like tablets, injections, or suspensions with defined excipients.
  • Method of preparation: Outlining synthetic routes or purification processes.
  • Therapeutic use: Covering treatment indications, often with claims of efficacy.

The patent likely balances broad compound claims with narrow process or product specifics, aiming to maximize scope without risking invalidity for lack of novelty or inventive step.

Patent Landscape for Argentina Pharmaceuticals

Understanding AR107990’s landscape entails examining:

  • Prior art references: Existing patents or publications in Argentina or international jurisdictions that disclose similar compounds or methods.
  • National and regional patent databases: Such as INPI, WIPO's PATENTSCOPE, and regional patent offices to assess overlaps.
  • Patent family analysis: To determine related filings across jurisdictions, indicating the patent’s strategic importance.
  • Legal challenges or litigation history: Signaling enforceability and novelty concerns.

Competitive and Non-Patent Literature

  • Patent overlap: Any prior patents sharing similar claims may limit scope or provide grounds for invalidation.
  • Scientific publications: New research or alternative formulations may indirectly influence patent validity or freedom-to-operate.

Patent Strategies in Argentina

Patent owners frequently file broad composition claims combined with narrower process or use claims. Such strategies aim to:

  • Block generic entry.
  • Cover multiple therapeutic indications.
  • Maintain patent life extensions.

Given Argentina’s adherence to international patent standards, compliance with the Patent Cooperation Treaty (PCT) and examination practices influences patent scope and defensibility.

Legal and Market Implications

The strength of AR107990’s claims directly affects market exclusivity:

  • Strong, broad claims can prevent competitors from entering specific segments.
  • Narrow claims may permit design-around strategies but are easier to challenge on validity grounds.
  • Potential for patent challenges exists if prior art or obviousness arguments arise, emphasizing the need for robust claim drafting.

In the context of Argentina’s pharmaceutical market, which features a growing emphasis on biosimilars and generics, patent analysis guides licensing decisions, litigation risk assessments, and R&D strategies.

Conclusion

Patent AR107990’s scope hinges on a carefully drafted set of claims that likely combine broad composition protections with narrower process and use claims. Its positioning within Argentina’s patent landscape reflects a strategic effort to secure exclusive rights over a novel pharmaceutical invention, with implications for market access and competitive positioning.


Key Takeaways

  • Claim Breadth Is Critical: Broad and well-drafted independent claims determine long-term patent strength; narrower claims may be more defensible but limit scope.
  • Landscape Analysis Is Essential: Regular review of prior art, patent families, and legal challenges ensures strategic positioning and maintains patent robustness.
  • Patent Strategy Matters: Combining broad composition claims with narrower method and use claims can effectively defend market exclusivity.
  • Legal Environment: Argentina’s patent law emphasizes literal claim interpretation; meaningful claim language is paramount.
  • Market Impact: Patents like AR107990 influence product lifecycle management, licensing, and potential entry barriers in Argentine and regional markets.

FAQs

  1. What is the typical validity period for AR107990 in Argentina?
    In Argentina, patents generally enjoy 20 years from the filing date, subject to annual maintenance fees. AR107990 is assumed to be valid unless challenged or lapsed.

  2. How can I determine if AR107990’s claims are enforceable?
    A detailed legal review comparing claims against prior art, evaluating novelty and inventive step, and assessing claim clarity determines enforceability.

  3. Does the patent cover specific therapeutic indications?
    If the patent includes use claims, it selectively protects therapeutic methods. Otherwise, claims may focus solely on the composition or process.

  4. What strategies can competitors adopt given the patent landscape?
    Competitors can explore designing around narrow claims, developing alternative compounds or processes, or challenging patent validity based on prior art.

  5. How does Argentina’s patent law compare regionally?
    Argentina’s patent regime aligns with international standards, emphasizing clear claim language and substantive examination, facilitating regional cooperation within Latin America.


References:

[1] National Institute of Industrial Property (INPI) Argentina - Patent Database
[2] World Intellectual Property Organization (WIPO) – Patent Landscape Reports
[3] Argentine Patent Law (Law No. 24,481) and amendments

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.